Ad copy

When we invested in Cardiex, the parent company of @conneqthealth, our vision was clear and ambitious: 1. Revolutionizing Cardiovascular Diagnostics: To disrupt 150 years of reliance on outdated sphygmomanometer technology, which has long been the primary tool for diagnosing and treating cardiovascular disease—the world’s leading cause of death—despite minimal innovation over the decades. 2. Transforming Vascular Monitoring Worldwide: To redefine the global standard of care with advanced devices and digital solutions that can more accurately predict and manage the risk of vascular-related diseases such as Alzheimer’s, kidney disease, preeclampsia, stroke, and heart failure. 3. Establishing Game-Changing Biomarkers: To introduce cutting-edge biomarkers like arterial stiffness, SEVR/Buckberg Index, central pulse pressures, and central aortic blood pressures, elevating them to the same level of ubiquity as cholesterol measurements today—yet with far greater impact on health outcomes. Arterial health must be at the forefront of any meaningful conversation about #longevity, #healthspan, and #lifespan. It’s the foundation of a healthier future.❤️